| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovaBridge Biosciences | Senior Vice President, Clinical Development Exhibit List: Ex. 24.1 - Power of Attorney | Ordinary Shares | 288,266 | 18 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBP | NovaBridge Biosciences | 18 Mar 2026 | 0 | $0 | 3 | Senior Vice President, Clinical Development Exhibit List: Ex. 24.1 - Power of Attorney | 18 Mar 2026, 21:35 |